| Dr Omar E Mendez-figueroa, MD | |
|
750 W 800 N, Orem, UT 84057-3660 | |
| (801) 714-6387 | |
| (801) 714-6596 |
| Full Name | Dr Omar E Mendez-figueroa |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 44 Years |
| Location | 750 W 800 N, Orem, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912034315 | NPI | - | NPPES |
| 01095005 | Medicaid | NY | |
| 173813A1 | Other | NY | PREFERRED CARE |
| 173813 | Other | NY | SHARED HEALTH |
| 91102 | Other | NY | MVP |
| 000462005001 | Other | NY | SENIOR BLUE |
| 10016748 | Other | NY | CDPHP |
| 86E161 | Other | NY | BLUE CROSS |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yuma Regional Medical Center | Yuma, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yuma Regional Medical Center | 2062314826 | 288 |
News Archive
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced it will offer clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx qualitative test from Dako, an Agilent Technologies company.
Melbourne-based nanotechnology company Starpharma will lead a consortium to develop a second generation microbicide for the prevention of infection by HIV and other sexually transmitted diseases (STDs).
As potentially effective new treatments for neurofibromatosis (NF) are developed, standardized research approaches—including outcome measures specific to NF—are needed. The first report from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration has been published as a supplement to Neurology, the Official Journal of the American Academy of Neurology (AAN).
Global leaders in cancer research and policy are calling on the scientific community and worldwide governments to unite against the disease.
Over half (52 percent) of supplement users are concerned about their heart health and 73 percent express an interest in natural, clinically proven solutions for cholesterol reduction, according to market research conducted by Micropharma Limited, a pioneer in the development of innovative and effective probiotics.
› Verified 8 days ago
| Entity Name | Yuma Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194706655 PECOS PAC ID: 2062314826 Enrollment ID: O20040122000526 |
News Archive
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced it will offer clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx qualitative test from Dako, an Agilent Technologies company.
Melbourne-based nanotechnology company Starpharma will lead a consortium to develop a second generation microbicide for the prevention of infection by HIV and other sexually transmitted diseases (STDs).
As potentially effective new treatments for neurofibromatosis (NF) are developed, standardized research approaches—including outcome measures specific to NF—are needed. The first report from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration has been published as a supplement to Neurology, the Official Journal of the American Academy of Neurology (AAN).
Global leaders in cancer research and policy are calling on the scientific community and worldwide governments to unite against the disease.
Over half (52 percent) of supplement users are concerned about their heart health and 73 percent express an interest in natural, clinically proven solutions for cholesterol reduction, according to market research conducted by Micropharma Limited, a pioneer in the development of innovative and effective probiotics.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Omar E Mendez-figueroa, MD 750 W 800 N, Orem, UT 84057-3660 Ph: (801) 714-6387 | Dr Omar E Mendez-figueroa, MD 750 W 800 N, Orem, UT 84057-3660 Ph: (801) 714-6387 |
News Archive
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced it will offer clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx qualitative test from Dako, an Agilent Technologies company.
Melbourne-based nanotechnology company Starpharma will lead a consortium to develop a second generation microbicide for the prevention of infection by HIV and other sexually transmitted diseases (STDs).
As potentially effective new treatments for neurofibromatosis (NF) are developed, standardized research approaches—including outcome measures specific to NF—are needed. The first report from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration has been published as a supplement to Neurology, the Official Journal of the American Academy of Neurology (AAN).
Global leaders in cancer research and policy are calling on the scientific community and worldwide governments to unite against the disease.
Over half (52 percent) of supplement users are concerned about their heart health and 73 percent express an interest in natural, clinically proven solutions for cholesterol reduction, according to market research conducted by Micropharma Limited, a pioneer in the development of innovative and effective probiotics.
› Verified 8 days ago
Dr. Richard I. Gelb I, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 W 800 N Ste 444, Orem, UT 84057 Phone: 801-714-6412 Fax: 801-714-6413 | |
Carl H Lawyer, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 700 W 800 N, Suite 220, Orem, UT 84057 Phone: 801-354-8205 Fax: 801-354-8206 | |
Jay S Cowen, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 W 800 N, Orem, UT 84057 Phone: 801-783-5011 | |
Ronald W Asay, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 700 W 800 N Ste 444, Orem, UT 84057 Phone: 801-714-6412 Fax: 801-714-6413 | |
Peter Duros, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 W 800 N Ste 400, Orem, UT 84057 Phone: 801-221-8811 Fax: 801-221-8805 | |
Sean R Curzon, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 W 800 N Ste 400, Orem, UT 84057 Phone: 801-221-8811 Fax: 801-221-8805 | |
Jerald P Boseman, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 121 S Orem Blvd Ste 103, Orem, UT 84058 Phone: 801-288-2634 Fax: 801-288-1186 |